Literature DB >> 32950464

Akirin is critical for early tinman induction and subsequent formation of the heart in Drosophila melanogaster.

Austin M Howard1, Hayley Milner2, Madison Hupp2, Courtney Willett2, Kristina Palermino1, Scott J Nowak3.   

Abstract

The regulation of formation of the Drosophila heart by the Nkx 2.5 homologue Tinman is a key event during embryonic development. In this study, we identify the highly conserved transcription cofactor Akirin as a key factor in the earliest induction of tinman by the Twist transcription cofactor. akirin mutant embryos display a variety of morphological defects in the heart, including abnormal spacing between rows of aortic cells and abnormal patterning of the aortic outflow tract. akirin mutant embryos have a greatly reduced level of tinman transcripts, together with a reduction of Tinman protein in the earliest stages of cardiac patterning. Further, akirin mutants have reduced numbers of Tinman-positive cardiomyoblasts, concomitant with disrupted patterning and organization of the heart. Finally, despite the apparent formation of the heart in akirin mutants, these mutant hearts exhibit fewer coordinated contractions in akirin mutants compared with wild-type hearts. These results indicate that Akirin is crucial for the first induction of tinman by the Twist transcription factor, and that the success of the cardiac patterning program is highly dependent upon establishing the proper level of tinman at the earliest steps of the cardiac developmental pathway.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Akirin; Cardiac; Drosophila; Embryonic development; Tinman; Twist

Mesh:

Substances:

Year:  2020        PMID: 32950464      PMCID: PMC7722205          DOI: 10.1016/j.ydbio.2020.09.001

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  1 in total

1.  Improved cardiac contraction imaging in live Drosophila embryos.

Authors:  Hayley Milner; Scott J Nowak
Journal:  MethodsX       Date:  2020-11-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.